Effects of interferon-α on peripheral neutrophil counts and serum granulocyte colony-stimulating factor levels in chronic hepatitis C patients

Cytokines, Cellular and Molecular Therapy

Volumn 6, Issue 3, 2000, Pages 149-154

  Fukuda, A ^a   Kobayashi, H ^a   Teramura, K ^a   Yoshimoto, S ^a   Ohsawa, N ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Bone marrow suppression; Granulocyte colony stimulating factor (G CSF); Interferon (IFN ); Negative feedback regulation; Neutropenia

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ARTICLE; CELL COUNT; CHEMOLUMINESCENCE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CORRELATION FUNCTION; DOSE TIME EFFECT RELATION; ENZYME IMMUNOASSAY; FEMALE; GRANULOCYTOPENIA; HEPATITIS C; HUMAN; IMMUNOTHERAPY; LONG TERM CARE; MALE; NEGATIVE FEEDBACK; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0034486375     PISSN: 13684736     EISSN: None     Source Type: Journal    
DOI: 10.1080/mccm.6.3.149.154     Document Type: Article

References (39)

1. The biology of interferon actions
2. The alpha interferons: Clinical overview
3. Interferon-α in malignant and viral diseases
4. Therapy of acute and chronic viral hepatitis
5. Clinical toxicity of interferons in cancer patients: A review
6. Inhibitory effects of interferon on mouse megakaryocytic progenitor cells in culture
7. Human leukocyte interferon preparation mediated block of granulopoietic differentiation in vitro
8. Effect of interferon on pluripotent haemopoietic progenitors (CFU-GEMM) derived from human bone marrow
9. Changes in the bone marrow of cancer patients treated with recombinant interferon alpha-2
10. In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor
11. Kinetics and mechanisms of recombinant human granulocyte colony-stimulating factor induced neutropenia
12. Biologic and clinical effects of granulocyte-stimulating factor in normal individuals
13. Chemiluminescent sandwich enzyme immunoassay for determination of human granulocyte colony-stimulating factor (G-CSF)
14. Sensitive chemiluminescent immunoassay for human granulocyte colony-stimulating factor (G-CSF) in clinical applications
15. Quantitive enzyme immunoassay for human granulocyte colony-stimulating factor (G-CSF)
16. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders estimated by enzyme immunoassay
17. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay
18. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers reduced from 5′-non-coding region
19. Virus elimination and histological improvement in patients with chronic hepatitis C treated with interferon alpha
20. Typing hepatitis C virus by polymerase chain reaction with type specific primers: Application to clinical surveys and tracing infectious sources
21. Genotypic subtyping of hepatitis C virus
22. Acute and chronic hepatitis revisited: Review
23. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
24. Interferon alpha primes early proliferative response of bone marrow cells in vivo
25. Interferon-gamma inhibits proliferation, but not commitment of murine granulocyte-macrophage progenitors
26. Interferon-induced nuclear signaling by Jak protein tyrosine kinases
27. Multichain structure of the IFN-α receptor on hematopoietic cells
28. Hematopoietic growth factors
29. Introduction and overview of hematopoietic growth factors
30. Drug therapy: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (first of two parts)
31. Drug therapy: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (second of two parts)
32. The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo
33. Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator
34. Myelosuppressive effects of antineoplastic drugs
35. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy
36. Recombinant human granulocyte colony-stimulating factor reduces hepatitis C virus replication in mononuclear cells from chronic hepatitis C patients
37. Successful treatment of end-stage liver disease due to hepatitis C prior to liver transplantation
38. Pilot study of recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of chronic hepatitis B
39. Use of granulocyte macrophage colony stimulating factor alone or in combination with interferon-alpha-2b for treatment of chronic hepatitis C